December 9, 2005
CORRECTED: Call for Vioxx mistrial:report
Corrects paragraph two and three to read Fallon
HOUSTON (Reuters) - Plaintiffs in the Vioxx trial filed a
motion seeking a mistrial, citing missing data from a key Merck
& Co. clinical study, according to The Wall Street Journal.
said he will take the plaintiffs' motion under advisement.
Judge Fallon's staff declined to comment to Reuters on
whether a mistrial motion was filed, as did both plaintiff and
The clerk of the court could not confirm whether such a
motion had been filed.
Merck shares traded 2 percent lower to $29.06 on the New
York Stock Exchange Friday.